---
{"dg-publish":true,"permalink":"/USMLE/Blood/Immune thrombocytopenia/","title":"Immune thrombocytopenia (ITP)"}
---


# Etiology
- Primary ITP: idiopathic (most common) 
- Secondary ITP associated with:
	- Autoimmune disorders: [[USMLE/Immunology/Systemic lupus erythematosus\|SLE]], [[USMLE/MSK/Antiphospholipid syndrome\|Antiphospholipid syndrome]]
	- Malignancy: lymphoma, leukemia (particularly CLL)
	- Infection: HIV, HCV
	- Drugs: e.g., quinine, beta-lactam antibiotics, carbamazepine, heparin, vaccines, linezolid, sulfonamides, vancomycin, TMP-SMX, antiepileptics

<mark style="background: #BBFABBA6;">The acute form is typically seen in children after a viral disease.</span>
# Pathophysiology
Antiplatelet antibodies (mostly IgG directed against, e.g., GpIIb/IIIa, GpIb/IX) bind to surface proteins on platelets → <span style="background:rgba(240, 200, 0, 0.2)">sequestration by spleen and liver</span> → ↓ platelet count → bone marrow megakaryocytes and platelet production increase in response (in most cases).
# Clinical features
- Mostly asymptomatic.<span style="background:rgba(240, 200, 0, 0.2)"> [[USMLE/Blood/Splenomegaly\|Splenomegaly]] is very unusual in ITP and makes other diagnoses more likely! </span>
	- Although platelets can undergo splenic sequestration in ITP, <span style="background:rgba(240, 200, 0, 0.2)">the primary mechanism responsible for the thrombocytopenia is immune destruction.</span>

---
# Differential diagnostics

| Feature          | **Thrombotic Thrombocytopenic Purpura (TTP)**                                                                                                                          | **Immune Thrombocytopenia (ITP)**                                                                                                               |
| :--------------- | :--------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :---------------------------------------------------------------------------------------------------------------------------------------------- |
| **Patho**        | ↓ ADAMTS13 activity → Large vWF multimers → microvascular platelet thrombi                                                                                             | Anti-platelet (anti-GpIIb/IIIa) Abs → splenic destruction of platelets                                                                          |
| **Presentation** | **Pentad (FAT RN):** **F**ever, **A**nemia (MAHA), **T**hrombocytopenia, **R**enal failure, **N**eurologic sx (e.g., confusion, stroke). Often acutely ill.            | Isolated mucocutaneous bleeding (petechiae, purpura, epistaxis). Often asymptomatic. No splenomegaly.                                           |
| **Labs**         | **MAHA** triad: **Anemia**, **Thrombocytopenia**, **Schistocytes** on smear. ↑LDH, ↑Bilirubin, ↓Haptoglobin. **Normal PT/PTT**. Dx confirmed by ADAMTS13 assay (<10%). | **Isolated thrombocytopenia** (<100,000/µL). Smear may show megathrombocytes. Otherwise normal CBC & smear. **Normal PT/PTT**. Dx of exclusion. |
| **Tx**           | **EMERGENT**. **Plasma exchange (PEX)** is first-line & life-saving. Corticosteroids, Rituximab. **Platelet transfusion is CONTRAINDICATED** (fuels thrombosis).       | **1st line:** Corticosteroids, IVIG. **2nd line:** Splenectomy, Rituximab, TPO-RAs (e.g., romiplostim). Observe if plt >30k & no bleeding.      |

![Pasted image 20230623160626.png](/img/user/appendix/Pasted%20image%2020230623160626.png)